chromosome led to speculation that this was responsible for male sexual differentiation. However, breeding experiments subsequently showed that the Y chromosome was not relevant and that sex was determined by the dosage of X chromosomes, a mechanism also operative in the primitive nematode worm Caenorhabditis. 3 As sex determination is highly evolutionarily conserved, it was assumed that the situation in man would be similar.
It was, though, by the study of individuals with anomalous sexual development, particularly those with a 45X karyotype whose genitalia were uniformly female, that refocused attention on the potential importance of the Y chromosome. 4 It was, however, only with the recognition that patients with Klinefelter syndrome who have a 47 XXY karyotype, invariably had testes, and were unequivocally male 5 that it was fully understood that in man the number of X chromosomes was not relevant to male sexual differentiation. The subsequent identification of other patients with 48 XXXY and 49 XXXXY karyotypes who also had testes and a male phenotype clearly confirmed this.
The Y chromosome is only one-third of the size of the X chromosome. Its short arm (Yp) contains 13 megabase pairs of DNA whereas the long arm (Yq) contains 46 megabase pairs, but because these form numerous repetitive sequences the Y chromosome was until very recently regarded largely as a genetic wasteland. 6 During cell division, the autosomes line up in pairs each making contact with its mate thereby exchanging some genetic material. Although the X and Y chromosomes are unpaired, they also make contact with each other although usually only at the tips of their long and short arms. These regions were therefore called the pseudoautosomal regions and were thought unlikely to harbor the unique sequences required for sex determination.
In 1966, a landmark observation was made by Jacobs and Ross. 7 They described two sisters who had female external genitalia but a 46 XY karyotype in which the Y chromosome consisted only of its long arm. It seemed probable, therefore, that the testicular determining region of the Y chromosome normally resides in its short arm. This was confirmed by high resolution banding studies of an XX male which revealed that Yp material had been translocated to one of his X chromosomes. 8 This was subsequently shown to be common among XX males and provides a straightforward explanation as to why these individuals have testes. The search for the specific gene responsible for male sex determination, now termed the Testis Determining Factor, was under way.
H-Y ANTIGEN
In the 1950's, it had been observed that when female mice were grafted with skin from isogenic males it was rejected. This indicated the Y chromosome probably contained a histocompatibility gene, which became known as the histocompatibility -Y-antigen. Wachtel 9 proposed this had a role in sex determination and reported finding expression of this gene in some XX males, although in others it seems to be absent. It was, however, only with the demonstration that XX male mice could have testes in spite of the absence of any detectable HY antigen 10 that is was finally accepted that H-Y antigen was not the testis determining factor.
ZFY GENE
By the 1980's, the development of molecular techniques allowed gene deletions to be studied in detail. By careful comparison of nucleotide sequences in XX males and XY females it was now possible to localize the testicular determining region to the distal portion of Yp immediately adjacent to the pseudoautosomal boundary. 11 Here, a 140 Kb interval, designated ZFY, was identified which encoded a protein with multiple zinc ìfingerî domains. This seemed to be a strong candidate for the testis determining factor but it was puzzling that ZFY was also present on the X chromosome and, moreover, that it was expressed in many other tissues besides the testis. The hypothesis that this was the gene for testicular determination had to be abandoned when XX phenotypic males were identified whose X chromosomes contained translocated Y material which was devoid FZY.
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SRY GENE
The search for the testis determining factor ended in 1990 when Sinclair, 13 also examining the translocated material in XX males, identified a 35 Kb sequence in the Yp 11.3 band immediately adjacent to the pseudoautosomal boundary which was identical to that found in normal males. This was confirmed to be evolutionarily conserved and appeared to be the only gene on the Y chromosome necessary for the development of the testis. It was named the Sex determining Region of the Y chromosome (SRY).
Support for the designation of SRY as the testis determining factor came from the study of mouse embryos where, in the genital ridge SRY was found to be expressed for only a very short period immediately proceeding the first appearance of the Sertoli cells. Furthermore, its expression could not be found in any other embryonic tissues and it was therefore testis specific. Conclusive evidence came from an elegant experiment in which a 14 Kb DNA fragment containing SRY but no other functioning genes was inserted into the genome of female mice embryos who, as a result, developed testes and external genitalia which were male.
14 The SRY gene is now known to comprise a single exon within which lie 237 base pairs which encode an evolutionarily highly conserved group of 79 aminoacids known as the HMG box, so called because of their homology to the widely distributed Highly Mobile Group of proteins. Collectively, this family of genes, 14 of which have so far been identified, has been named the SRY HMG box or ìSOXî gene family.
The SRY gene acts as a transcription factor. Its protein product recognizes a specific DNA sequence AACAAT to which it becomes bound. 15 A non-polar side chain first inserts into a minor groove of the DNA double helix which then undergoes an acute bend of approximately 80 degrees 16 , resulting in widening of the groove and partial unwinding of the DNA helix. 17 This special rearrangement of the double helix brings into close approximation regions of DNA on either side of the SRY target site, thus potentially making available other sites to which further transcription factors might bind, although these have yet to be identified. The critical importance of the HMG box can be seen in patients with point mutations or microdeletions in this region of the SRY gene where a single aminoacid substitution can lead to profound alterations in the ability of the protein to bind or bend DNA.
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OTHER TESTICULAR PATHWAY GENES
Although it is now clear that the SRY gene plays a central role in triggering the formation of the testis two puzzling groups of patients indicate that other genes, located either on the X chromosome or on autosomes, must also be involved in testicular differentiation. Firstly, although some XY females have mutations or deletions in their SRY gene which explain why they do not have testes, in approximately 85% of such cases the SRY gene appears to be normal. Furthermore, although the majority of XX males have a translocation of their SRY gene, in approximately 20% of cases this cannot be detected. It is also known that in several clinical syndromes resulting from autosomal deletions or mutations testicular development is impaired. It is by studying these patients that further light has been shed on the testicular developmental pathway.
WT-1 GENE
Among patients with the WAGR (Wilmsí tumor, Aniridia, Genital malformations and mental Retardation) syndrome the testes are frequently dysgenetic with a propensity to form gonadoblastomas. Gonadal dysgenesis and genital ambiguity are also features of the related Denys-Drash syndrome which, in addition to Wilmsí tumor, is characterized by an early onset protein losing nephropathy. In these syndromes deletions have been detected in the WT-1 tumor suppressor gene located in the chromosome 11p13 band. 19 These clinical observations focused attention on the role of WT-1 in testicular development. Examination of human embryos has revealed that WT-1 is expressed not only, as expected, in the developing kidney but also in the primitive gonad indicating that here too it plays a role. 20 This is supported by studies of mice bred with a null mutation of the WT-1 gene. It was found that embryos homozygous for this deletion had in addition to bilateral renal agenesis complete absence of ovaries or testes. This indicated that the WT-1 tumor suppressor gene is essential early on in the formation of the indifferent gonad from the intermediate mesoderm 21 , thus placing WT-1 upstream of SRY in the testicular developmental cascade.
SF-1
Steroidogenic factor 1 (SF-1) is a nuclear receptor protein, the gene for which has been mapped to chromosome 9. It regulates the production of the hydroxylase enzymes necessary for the synthesis of steroids and is therefore expressed in many tissues throughout the body including the adrenal gland, ovary and Leydig cells of the testis. It was a surprise, therefore, when SF-1 transcripts were detected in the mouse urogenital ridge at the stage of the indifferent gonad before the Leydig cells had appeared. 22 This suggested that in addition to its steroidogenic role, SF-1, is also an early player in the testicular developmental cascade.
In order to test this hypothesis, mice were bred with a deletion for the fushi tarazu factor 1 (Ftz-F1) gene, which is structurally very similar to SF-1. At birth the animals appeared normal but within a few days all died from adrenal insufficiency. At autopsy, all were found to be completely lacking not only in adrenal glands but also in gonads, thus confirming the pivotal role of SF-1 in early gonadal development. 23 Within the testis SF-1 acts not only to establish Leydig cell testosterone biosynthesis but is also expressed in the Sertoli cells where it appears to act as a regulator of AMH production. 24 The SRY gene also seems to have a regulatory effect on AMH production but whether SRY and SF-1 themselves interact in some way is presently not clear. 25 
SOX-9
Among the SOX family of genes, SOX-9, which has been assigned to chromosome 17, appears to be a candidate for a role in testicular development. Mutations of this gene are routinely found in patients of both sexes with campomelic dysplasia, a dominantly inherited and usually fatal osteochondrodysplasia. 26 Among those with an XY karyotype approximately 75% also have dysgenetic gonads which give rise to ambiguous genitalia which is a characteristic feature of this condition.
Studies of normal human fetuses have shown SOX-9 to be expressed, as expected, in chondrocytes but also in the differentiated testis indicating that it has a role relatively late in the developmental pathway. 27 In addition a recent report suggests that, at least in the mouse, SOX-9 is also expressed early in the genital ridge before any gonadal differentiation has occurred. 28 Its precise role at these sites is presently unclear although it may possibly be concerned with the formation of connective tissue upon which the integrated architecture of both the bones and the testes depends.
DAX-1 GENE
In 1980, Bernstein 29 reported a pair of female siblings with dysgenetic gonads who had a 46 XY karyotype in which a portion of the short arm of the X chromosome was duplicated. This raised the question whether suppression of their testes was the result of a double dose of X material, reminiscent of the sex determining mechanism in the fruitfly and nematode. Other cases have subsequently been identified in whom the SRY gene was intact but who, in addition, had an X fragment of 160 kilobases duplicating part of the Xp21 band. 30 This was named the Dosage Sensitive Sex reversal region of the X (DSS) which overlaps a locus where deletions are known to occur in patients with adrenal hypoplasia congenita. The gene responsible for sex reversal in these cases was therefore designated DAX-1 (for DSS-AHC critical region of X) which is now known to encode a nuclear hormone receptor protein. 31 Until very recently it was doubtful that DAX-1 played any role in the development of the testes for, although cryptorchidism is sometimes seen with adrenal hypoplasia congenita, these patients invariably have testes and normal male external genitalia. It was thought to have a role in ovarian development but the recent finding that DAX-1 is expressed in the mouse genital ridge 32 suggests that, as well as adrenal development, this gene may be important early on in the formation of the indifferent gonad.
OTHER AUTOSOMAL GENES:
Evidence for the involvement of other genes in the development and differentiation of the gonads comes from several case reports. Bennett 33 described a 46XY female with gonadal dysgenesis in whom a terminal deletion was found in the short arm of chromosome 9. Another XY patient with ambiguous genitalia and testicular dysgenesis was reported by Wilkie 34 in whom a deletion was noted in the long arm of chromosome 10. Gonadal dysgenesis with subsequent phenotypic ambiguity is also a feature of a number of disorders including the Smith-Lemli-Opitz syndrome, the genito-palato-cardiac, and the alpha thalassemia and mental retardation syndromes.
CONCLUSIONS
Over the past 50 years our understanding of the role of the Y chromosome in determining the sex of the embryo has progressively evolved from initial doubt as to its importance to an appreciation of its key role which came in 1990 with the cloning of the SRY gene. Since then we have learned how the SRY gene product recognizes, binds to and distorts its target DNA, a process which most likely initiates yet more steps in the cascade, although precisely what these are remains to be discovered. What has become clear is it that SRY is not the only gene necessary to form a testis (see Table) . We now know that the WT-1 and SF-1 genes, as well as possibly SOX-9 and DAX-1 are also needed for the early induction of the indifferent gonad. Furthermore, it is becoming apparent that several of these genes act not only at more than one site in the developmental cascade but also in more than one organ system in the body. 35 The figure summarizes the steps presently known to be involved in the development and differentiation of a functioning testis (see Figure) .
Hitherto, our assumption has been that all of the above genes act as transcription activators, each triggering in a positive way the next step along a cascade. Yet several paradoxes remain. How is it possible, for example, that some XX males seem to be totally lacking in SRY, yet the majority of XY females seem to be amply endowed with this gene? To explain these puzzles McElreavy 36 proposed that the SRY gene product acts not as an activator but primarily as a repressor of another hitherto unidentified gene ìZî the role of which is to inhibit testis formation. This, and other models are currently being explored to explain the remaining clinical and experimental puzzles. Although tantalizingly near, we are still a little way from finally understanding the molecular complexities of testicular development. 
